.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Fuji
Colorcon
Boehringer Ingelheim
Merck
Medtronic
Baxter
Covington
Johnson and Johnson
Queensland Health

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019961

« Back to Dashboard
NDA 019961 describes GANITE, which is a drug marketed by Chapter 7 Trustee and is included in one NDA. It is available from one supplier. Additional details are available on the GANITE profile page.

The generic ingredient in GANITE is gallium nitrate. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gallium nitrate profile page.

Summary for NDA: 019961

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019961

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GANITE
gallium nitrate
INJECTABLE;INJECTION 019961 NDA Genta Incorporated 66657-301 66657-301-05 5 VIAL, SINGLE-USE in 1 CARTON (66657-301-05) > 20 mL in 1 VIAL, SINGLE-USE (66657-301-01) (66657-301-01)

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 17, 1991TE:RLD:No

Expired Orange Book Patents for NDA: 019961

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chapter 7 Trustee
GANITE
gallium nitrate
INJECTABLE;INJECTION019961-002Jan 17, 19914,529,593► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Accenture
Johnson and Johnson
Moodys
Deloitte
Queensland Health
Merck
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot